Whalegun
Lobbying

Maridose's latest lobbying report covers Q1 2025, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Medical/Disease Research/Clinical Labs.

Maridose

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Maridose lobbying by quarter
Maridose lobbying by quarter
QuarterAmountReports
Q4 2022$01
Q1 2023$01
Q2 2023$230K1
Q3 2023$10K1
Q4 2023$10K1
Q1 2024$10K1
Q2 2024$01
Q3 2024$10K1
Q4 2024$10K1
Q1 2025$01
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Medical research and clinical labs$280K · 9 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES6 reports
  • SENATE6 reports
  • Drug Enforcement Administration (DEA)4 reports
  • Justice, Dept of (DOJ)2 reports
  • White House Office1 reports

Firms it paid

Firm
Brownstein Hyatt Farber Schreck$280K10 quarters

Former officials lobbying for it

Former position
ADAM STEINMETZPolicy Advisor - Committee on the Budget, United States House of RepresentativesQ4 2023

Lobbying reports

Filed by
25/04/18for Q1 2025Brownstein Hyatt Farber SchreckUnder $5,000
25/01/20for Q4 2024Brownstein Hyatt Farber Schreck$10K
24/10/17for Q3 2024Brownstein Hyatt Farber Schreck$10K
24/07/19for Q2 2024Brownstein Hyatt Farber SchreckUnder $5,000
24/04/17for Q1 2024Brownstein Hyatt Farber Schreck$10K
24/01/17for Q4 2023Brownstein Hyatt Farber Schreck$10K
23/10/19for Q3 2023Brownstein Hyatt Farber Schreck$10K
23/07/19for Q2 2023Brownstein Hyatt Farber Schreck$230K
23/04/18for Q1 2023Brownstein Hyatt Farber SchreckUnder $5,000
23/01/19for Q4 2022Brownstein Hyatt Farber SchreckUnder $5,000